Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Scpharmaceuticals Inc's Business Segments
Scpharmaceuticals Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
1
Largest Segment
Segment
Total Revenue
$ 16
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Segment100%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Segment | $ 16 | 100% |
Annual Results
Revenue Share by Reportable Segment - FY
- Segment100%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Segment | $ 16 | 100% |
Description of Scpharmaceuticals Inc
SCPharmaceuticals Inc. is a pharmaceutical company that specializes in the development of innovative, simple, and convenient therapies for patients with acute and chronic conditions that require frequent injections or infusions. The company was founded in 2013 and is headquartered in Burlington, Massachusetts, with additional locations in Rhode Island and California.
The primary goal of SCPharmaceuticals is to revolutionize the way patients receive medications by providing them with easy-to-use, portable, and cost-effective options that can be administered outside of traditional healthcare settings. The company's product portfolio includes the Furoscix™ (furosemide injection) platform, which is a subcutaneous infusion system designed for patients who require diuretic therapy for heart failure.
Furoscix™ is a portable and convenient infusion system that enables patients to self-administer furosemide at home, thereby reducing the need for repeated hospitalizations and improving patient outcomes. The product has demonstrated significant clinical benefits in multiple Phase III clinical trials, including reduced hospitalizations, improved quality of life, and a lower risk of adverse events.
SCPharmaceuticals is also developing other innovative products for the treatment of various conditions, including infectious diseases, metabolic disorders, and inflammatory diseases. The company's pipeline includes several promising candidates, such as the Antibiotic Site Infusion System (ASIS) platform, which is a novel, easy-to-use infusion system for delivering antimicrobial agents to patients with bacterial infections.
Overall, SCPharmaceuticals is dedicated to providing patients with effective, convenient, and affordable therapies that improve their quality of life and reduce the burden of chronic diseases. With its innovative products and commitment to patient-centered care, the company has become a leader in the field of subcutaneous drug delivery and is poised for continued growth and success in the years ahead.
The primary goal of SCPharmaceuticals is to revolutionize the way patients receive medications by providing them with easy-to-use, portable, and cost-effective options that can be administered outside of traditional healthcare settings. The company's product portfolio includes the Furoscix™ (furosemide injection) platform, which is a subcutaneous infusion system designed for patients who require diuretic therapy for heart failure.
Furoscix™ is a portable and convenient infusion system that enables patients to self-administer furosemide at home, thereby reducing the need for repeated hospitalizations and improving patient outcomes. The product has demonstrated significant clinical benefits in multiple Phase III clinical trials, including reduced hospitalizations, improved quality of life, and a lower risk of adverse events.
SCPharmaceuticals is also developing other innovative products for the treatment of various conditions, including infectious diseases, metabolic disorders, and inflammatory diseases. The company's pipeline includes several promising candidates, such as the Antibiotic Site Infusion System (ASIS) platform, which is a novel, easy-to-use infusion system for delivering antimicrobial agents to patients with bacterial infections.
Overall, SCPharmaceuticals is dedicated to providing patients with effective, convenient, and affordable therapies that improve their quality of life and reduce the burden of chronic diseases. With its innovative products and commitment to patient-centered care, the company has become a leader in the field of subcutaneous drug delivery and is poised for continued growth and success in the years ahead.
Scpharmaceuticals Inc operates primarily within the healthcare sector, and its business is divided into two major segments: BioPharmaceuticals and Medical Devices. Each segment encompasses a variety of innovative products and services designed to address multiple medical needs and improve patient care.
Segments
1. BioPharmaceuticals: This segment focuses on the development and commercialization of biopharmaceutical products that primarily aid in the treatment of serious health conditions. The company emphasizes the importance of delivering effective medications that enhance patient outcomes while ensuring ease of use and accessibility.
2. Medical Devices: Scpharmaceuticals Inc also specializes in medical devices that provide unique therapeutic solutions. This segment highlights the company’s commitment to integrating technology with healthcare to deliver advanced therapies in a user-friendly manner.
Products and Services
1. Furosemide Injection
- Description: A potent diuretic used to treat fluid retention due to conditions such as heart failure, liver disease, and kidney disorders.
- Formulation: Available in a pre-filled, single-use syringe, making it easier for healthcare providers to administer while minimizing waste and improving safety.
- Benefits: Streamlined administration offers potential for improved patient outcomes, particularly in acute settings.
CleveR Patch
- Description: An innovative medical device designed to provide an advanced form of Rehydration Therapy for acute dehydration.
- Mechanism: This wearable system enables rapid hydration through skin absorption, allowing it to effectively deliver electrolytes without the need for intravenous therapy.
- Applications: Suitable for both hospital and outpatient settings, particularly beneficial for patients unable to maintain hydration orally.
Subcutaneous Ceftriaxone
- Description: A broad-spectrum antibiotic effective against a variety of bacterial infections.
- Innovation: Scpharmaceuticals provides a unique formulation that allows for self-administration via subcutaneous injection, facilitating home treatment and reducing hospitalization rates.
- Target Audience: This product is particularly advantageous for patients with limited access to healthcare facilities or those who prefer home care options.
GammaCore
- Description: A non-invasive, portable device designed to alleviate symptoms associated with migraines and cluster headaches.
- Technology: It works by stimulating the vagus nerve, offering a novel alternative for patients who do not respond well to traditional migraine treatments or those who face side effects.
- Approval: FDA-approved, ensuring that it meets rigorous safety and efficacy standards.
VIBEX Epinephrine
- Description: An auto-injector device for the treatment of severe allergic reactions (anaphylaxis).
- Design: Compact and user-friendly, VIBEX is intended to be intuitive for patients to use in emergency situations, designed with affordability in mind.
- Significance: It helps bridge the gap for patients who may face challenges in accessing emergency care during critical allergic reactions.
Urgent PC
- Description: A medical device providing Percutaneous Tibial Nerve Stimulation (PTNS) therapy, which addresses bladder function issues in patients with overactive bladder symptoms.
- Non-invasive Nature: The treatment can be performed in an outpatient setting, significantly enhancing patient comfort and convenience.
- Outcome: Aimed at improving quality of life by alleviating uncomfortable bladder-related symptoms without invasive procedures.
Additional Services
Beyond its product offerings, Scpharmaceuticals Inc is dedicated to enhancing the patient experience through a robust suite of support services:
- Reimbursement Assistance: Helping patients navigate the complexities of insurance and payment options to ensure access to medications and devices.
- Medication Counseling: Providing patients and caregivers with comprehensive information about the proper use of prescribed products to optimize outcomes.
- Product Education: Offering resources and training to both patients and healthcare providers to ensure that products are utilized effectively.
Scpharmaceuticals Inc’s commitment to delivering innovative, patient-centric solutions is evident in its extensive range of products and supportive services, which aim to improve health outcomes and enhance the quality of life for patients across various healthcare settings.
Segments
1. BioPharmaceuticals: This segment focuses on the development and commercialization of biopharmaceutical products that primarily aid in the treatment of serious health conditions. The company emphasizes the importance of delivering effective medications that enhance patient outcomes while ensuring ease of use and accessibility.
2. Medical Devices: Scpharmaceuticals Inc also specializes in medical devices that provide unique therapeutic solutions. This segment highlights the company’s commitment to integrating technology with healthcare to deliver advanced therapies in a user-friendly manner.
Products and Services
1. Furosemide Injection
- Description: A potent diuretic used to treat fluid retention due to conditions such as heart failure, liver disease, and kidney disorders.
- Formulation: Available in a pre-filled, single-use syringe, making it easier for healthcare providers to administer while minimizing waste and improving safety.
- Benefits: Streamlined administration offers potential for improved patient outcomes, particularly in acute settings.
CleveR Patch
- Description: An innovative medical device designed to provide an advanced form of Rehydration Therapy for acute dehydration.
- Mechanism: This wearable system enables rapid hydration through skin absorption, allowing it to effectively deliver electrolytes without the need for intravenous therapy.
- Applications: Suitable for both hospital and outpatient settings, particularly beneficial for patients unable to maintain hydration orally.
Subcutaneous Ceftriaxone
- Description: A broad-spectrum antibiotic effective against a variety of bacterial infections.
- Innovation: Scpharmaceuticals provides a unique formulation that allows for self-administration via subcutaneous injection, facilitating home treatment and reducing hospitalization rates.
- Target Audience: This product is particularly advantageous for patients with limited access to healthcare facilities or those who prefer home care options.
GammaCore
- Description: A non-invasive, portable device designed to alleviate symptoms associated with migraines and cluster headaches.
- Technology: It works by stimulating the vagus nerve, offering a novel alternative for patients who do not respond well to traditional migraine treatments or those who face side effects.
- Approval: FDA-approved, ensuring that it meets rigorous safety and efficacy standards.
VIBEX Epinephrine
- Description: An auto-injector device for the treatment of severe allergic reactions (anaphylaxis).
- Design: Compact and user-friendly, VIBEX is intended to be intuitive for patients to use in emergency situations, designed with affordability in mind.
- Significance: It helps bridge the gap for patients who may face challenges in accessing emergency care during critical allergic reactions.
Urgent PC
- Description: A medical device providing Percutaneous Tibial Nerve Stimulation (PTNS) therapy, which addresses bladder function issues in patients with overactive bladder symptoms.
- Non-invasive Nature: The treatment can be performed in an outpatient setting, significantly enhancing patient comfort and convenience.
- Outcome: Aimed at improving quality of life by alleviating uncomfortable bladder-related symptoms without invasive procedures.
Additional Services
Beyond its product offerings, Scpharmaceuticals Inc is dedicated to enhancing the patient experience through a robust suite of support services:
- Reimbursement Assistance: Helping patients navigate the complexities of insurance and payment options to ensure access to medications and devices.
- Medication Counseling: Providing patients and caregivers with comprehensive information about the proper use of prescribed products to optimize outcomes.
- Product Education: Offering resources and training to both patients and healthcare providers to ensure that products are utilized effectively.
Scpharmaceuticals Inc’s commitment to delivering innovative, patient-centric solutions is evident in its extensive range of products and supportive services, which aim to improve health outcomes and enhance the quality of life for patients across various healthcare settings.